Cargando…

Phage Display: A Powerful Technology for the Generation of High-Specificity Affinity Reagents from Alternative Immune Sources

Antibodies are critical reagents in many fundamental biochemical methods such as affinity chromatography, enzyme-linked immunosorbent assays (ELISA), flow cytometry, western blotting, immunoprecipitation, and immunohistochemistry techniques. As our understanding of the proteome becomes more complex,...

Descripción completa

Detalles Bibliográficos
Autores principales: Finlay, William J. J., Bloom, Laird, Grant, Joanne, Franklin, Edward, Shúilleabháin, Deirdre Ní, Cunningham, Orla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153406/
https://www.ncbi.nlm.nih.gov/pubmed/27730550
http://dx.doi.org/10.1007/978-1-4939-6412-3_6
_version_ 1783521647216558080
author Finlay, William J. J.
Bloom, Laird
Grant, Joanne
Franklin, Edward
Shúilleabháin, Deirdre Ní
Cunningham, Orla
author_facet Finlay, William J. J.
Bloom, Laird
Grant, Joanne
Franklin, Edward
Shúilleabháin, Deirdre Ní
Cunningham, Orla
author_sort Finlay, William J. J.
collection PubMed
description Antibodies are critical reagents in many fundamental biochemical methods such as affinity chromatography, enzyme-linked immunosorbent assays (ELISA), flow cytometry, western blotting, immunoprecipitation, and immunohistochemistry techniques. As our understanding of the proteome becomes more complex, demand is rising for rapidly generated antibodies of higher specificity than ever before. It is therefore surprising that few investigators have moved beyond the classical methods of antibody production in their search for new reagents. Despite their long-standing efficacy, recombinant antibody generation technologies such as phage display are still largely the tools of biotechnology companies or research groups with a direct interest in protein engineering. In this chapter, we discuss the inherent limitations of classical polyclonal and monoclonal antibody generation and highlight an attractive alternative: generating high-specificity, high-affinity recombinant antibodies from alternative immune sources such as chickens, via phage display.
format Online
Article
Text
id pubmed-7153406
institution National Center for Biotechnology Information
language English
publishDate 2016
record_format MEDLINE/PubMed
spelling pubmed-71534062020-04-13 Phage Display: A Powerful Technology for the Generation of High-Specificity Affinity Reagents from Alternative Immune Sources Finlay, William J. J. Bloom, Laird Grant, Joanne Franklin, Edward Shúilleabháin, Deirdre Ní Cunningham, Orla Protein Chromatography Article Antibodies are critical reagents in many fundamental biochemical methods such as affinity chromatography, enzyme-linked immunosorbent assays (ELISA), flow cytometry, western blotting, immunoprecipitation, and immunohistochemistry techniques. As our understanding of the proteome becomes more complex, demand is rising for rapidly generated antibodies of higher specificity than ever before. It is therefore surprising that few investigators have moved beyond the classical methods of antibody production in their search for new reagents. Despite their long-standing efficacy, recombinant antibody generation technologies such as phage display are still largely the tools of biotechnology companies or research groups with a direct interest in protein engineering. In this chapter, we discuss the inherent limitations of classical polyclonal and monoclonal antibody generation and highlight an attractive alternative: generating high-specificity, high-affinity recombinant antibodies from alternative immune sources such as chickens, via phage display. 2016-05-23 /pmc/articles/PMC7153406/ /pubmed/27730550 http://dx.doi.org/10.1007/978-1-4939-6412-3_6 Text en © Springer Science+Business Media New York 2017 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Finlay, William J. J.
Bloom, Laird
Grant, Joanne
Franklin, Edward
Shúilleabháin, Deirdre Ní
Cunningham, Orla
Phage Display: A Powerful Technology for the Generation of High-Specificity Affinity Reagents from Alternative Immune Sources
title Phage Display: A Powerful Technology for the Generation of High-Specificity Affinity Reagents from Alternative Immune Sources
title_full Phage Display: A Powerful Technology for the Generation of High-Specificity Affinity Reagents from Alternative Immune Sources
title_fullStr Phage Display: A Powerful Technology for the Generation of High-Specificity Affinity Reagents from Alternative Immune Sources
title_full_unstemmed Phage Display: A Powerful Technology for the Generation of High-Specificity Affinity Reagents from Alternative Immune Sources
title_short Phage Display: A Powerful Technology for the Generation of High-Specificity Affinity Reagents from Alternative Immune Sources
title_sort phage display: a powerful technology for the generation of high-specificity affinity reagents from alternative immune sources
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153406/
https://www.ncbi.nlm.nih.gov/pubmed/27730550
http://dx.doi.org/10.1007/978-1-4939-6412-3_6
work_keys_str_mv AT finlaywilliamjj phagedisplayapowerfultechnologyforthegenerationofhighspecificityaffinityreagentsfromalternativeimmunesources
AT bloomlaird phagedisplayapowerfultechnologyforthegenerationofhighspecificityaffinityreagentsfromalternativeimmunesources
AT grantjoanne phagedisplayapowerfultechnologyforthegenerationofhighspecificityaffinityreagentsfromalternativeimmunesources
AT franklinedward phagedisplayapowerfultechnologyforthegenerationofhighspecificityaffinityreagentsfromalternativeimmunesources
AT shuilleabhaindeirdreni phagedisplayapowerfultechnologyforthegenerationofhighspecificityaffinityreagentsfromalternativeimmunesources
AT cunninghamorla phagedisplayapowerfultechnologyforthegenerationofhighspecificityaffinityreagentsfromalternativeimmunesources